Autolus Therapeutics plc Files S-1
Ticker: AUTL · Form: S-1 · Filed: May 8, 2025 · CIK: 1730463
| Field | Detail |
|---|---|
| Company | Autolus Therapeutics PLC (AUTL) |
| Form Type | S-1 |
| Filed Date | May 8, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, s-1, registration-statement, biotechnology
TL;DR
Autolus Therapeutics just filed an S-1, get ready for a potential stock event.
AI Summary
Autolus Therapeutics plc filed an S-1 registration statement on May 8, 2025, for an unspecified offering. The company, incorporated in England and Wales, is based in London and operates in the biological products sector. This filing indicates a potential upcoming event for the company, such as a stock offering or other securities-related transaction.
Why It Matters
This S-1 filing signals a potential new offering or significant corporate event for Autolus Therapeutics, which could impact its stock and the biotechnology sector.
Risk Assessment
Risk Level: medium — S-1 filings are standard for public offerings but can precede significant stock price movements based on the offering details and market reception.
Key Players & Entities
- Autolus Therapeutics plc (company) — Registrant
- May 8, 2025 (date) — Filing Date
- England and Wales (jurisdiction) — Place of Incorporation
- London (location) — Principal Executive Offices
- Autolus Inc. (company) — Agent for Service
FAQ
What is the purpose of this S-1 filing?
The S-1 filing is a registration statement required by the SEC for companies planning to offer securities to the public. The specific details of the offering (e.g., number of shares, price range) are not yet disclosed in this initial filing.
When was Autolus Therapeutics plc incorporated?
Autolus Therapeutics plc was incorporated in England and Wales.
Where are Autolus Therapeutics plc's principal executive offices located?
The principal executive offices are located at The MediaWorks, 191 Wood Lane, White City, London W12 7FP, United Kingdom.
Who is the agent for service for Autolus Therapeutics plc in the United States?
The agent for service in the United States is Autolus Inc., located at 15810 Gaither Drive, Gaithersburg, Maryland 20877.
What is the SIC code for Autolus Therapeutics plc?
The Standard Industrial Classification (SIC) code for Autolus Therapeutics plc is 2836, which corresponds to Biological Products (No Diagnostic Substances).
Filing Details
This Form S-1 (Form S-1) was filed with the SEC on May 8, 2025 regarding Autolus Therapeutics plc (AUTL).